Amniotic & Placental Allografts

How amniotic & placental allografts works

Healix360 supports access to advanced mobile wound care services for patients throughout our coverage area. Services are delivered by licensed physicians and nurse practitioners experienced in the evaluation and management of chronic and complex wounds. Care is coordinated and provided directly to patients in private residences, assisted living communities, and skilled nursing facilities. Placental tissues are naturally designed by the body to support rapid fetal growth and protect against infection without triggering an immune response. When applied to a chronic wound, these allografts release a massive concentration of over 200 growth factors, cytokines, and a rich collagen matrix. This powerfully disrupts the chronic inflammatory cycle, signals local stem cells to migrate, and accelerates the formation of new blood vessels (angiogenesis) and tissue.

When it may be used

A licensed clinician determines whether this treatment is appropriate after evaluating the wound and the patient's medical history.

• Stalled diabetic foot ulcers and chronic venous leg ulcers.
• Complex wounds exposing bone, tendon, or hardware.
• Burns and severe radiation-induced tissue necrosis.
• Wounds in patients with significantly compromised natural healing ability.

When it may not be appropriate

Treatment decisions are individualized. Potential contraindications and precautions may include:

• Active, uncontrolled systemic or localized wound infection.
• Wounds with heavy amounts of necrotic tissue (must be debrided first).
• Severe, untreated peripheral arterial disease.

What to expect

Following thorough debridement to prepare the wound bed, the clinician will apply the ultra-thin amniotic membrane directly to the wound surface. It is then covered with protective, non-adherent dressings. The graft integrates directly into your tissue over the following week, so it is not 'removed' during the next visit—rather, new tissue grows over and through it.

Evidence and clinical context

Amniotic allografts have shown exceptional clinical efficacy. Studies published in major wound care journals demonstrate that amniotic membrane grafts significantly reduce time to healing and increase the overall incidence of complete wound closure in refractory diabetic foot ulcers compared to standard moist wound therapy.

Frequently Asked Questions

Is the tissue safe and screened for diseases?

Absolutely. The tissue is recovered from healthy mothers following extensive medical screening and rigorous FDA-regulated communicable disease testing. The tissue then undergoes stringent sterilization processes before clinical use.

Will my body reject the tissue?

No. Amniotic and placental tissues are inherently 'immune-privileged,' meaning they do not express the antigens that typically trigger an immune rejection response. They are safely accepted by the patient's body.

Does the graft need to be removed?

No. The allograft is biologically active and acts as a scaffold. Your body's cells will migrate into the matrix, essentially absorbing and replacing the graft with your own newly generated tissue.

Can this be done in a nursing home?

Yes. Healix360 coordinates care so that our licensed providers can apply these advanced biological therapies directly at the bedside in skilled nursing facilities, avoiding the need for hospital transport.

How long does it take to see results?

While every patient is different, clinical changes—such as a significant reduction in wound depth and the appearance of healthy red tissue—are often visible within one to two weeks following the initial application.